ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma

· Paracrine, INC.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma, covering 2022-09-28 to 2022-09-28. Get the full timeline:

Most recent: Clinical Trial Update: ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma [Phase 3]

See pricing